3 research outputs found
Efficacy of adjuvanted split H5N1-vaccine against a heterologous H5N1 challenge in ferrets.
a<p>TCID<sub>50</sub> per gram of lung tissue on Day 5 post-challenge or the day of the death</p>b<p>Virus titration (TCID<sub>50 </sub>per ml of swab) in the Upper Respiratory Tract (URT) from throat and nasal swabs collected on days 2,3,4 and 5 post-challenge until day of death.</p>c<p>% survival on day 5 post challenge</p
Neutralizing antibody responses to the vaccine strain (A/Vietnam) and the challenge strain (A/Indonesia) 42 days after first vaccination, i.e 21 days after second vaccination
a<p>Neutralizing antibody GMT were <28 before immunization (Day 0) and after first vaccination (Day 21 Post I).</p>b<p>A responder is defined by neutralizing titers ≥ 28.</p